ISPC vs VTR · rev $9.3M vs P/E 149, rev $4.92B
iSpecimen Inc (ISPC) versus Ventas Inc (VTR) — a side-by-side from cached financials, not a winner call.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Ventas Inc (VTR) is a reit - healthcare facilities company listed on NYSE.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
Latest reported VTR revenue for 2024-12-31 was $4.92B. Net income was $88.4M. Revenue was up 9.5% from 2023-12-31 to 2024-12-31. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
ISPC currently screens at market cap $4.4M. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
Not investment advice. Open the ISPC and VTR stock pages for the full models.
Not investment advice.